Category: Prostate Cancer Radiation

Can I live the rest of my life without the cancer coming back? That simple question sits at the heart of a recent opinion piece in Urology Times. Even after surgery or radiation with intent to cure, 20 to 40% of prostatectomy patients see a rising PSA within 10 years, and many men feel anxious before every follow-up test. keep reading

No study has ever compared focal laser ablation and radiation head to head. The two fields even define failure differently, one by the need for retreatment and the other by a rising PSA. That makes a fair comparison harder than it looks, and makes understanding what each number actually measures essential before choosing. keep reading

There's a saying that less is more. For men with intermediate-risk prostate cancer weighing hormone therapy on top of radiation, that phrase turns out to be more than a proverb. Five-year results from a landmark 1,492-patient trial found better cancer control in the combined group, no survival difference, and a real cost in side effects. keep reading

What if the very cells meant to protect your body are being hijacked to shield a tumor? In metastatic prostate cancer, that's exactly what can happen. Researchers are now launching a clinical trial to test whether combining radiation with targeted immune drugs can break through this defense and potentially point the way toward a cure. keep reading

Emerging research reveals that early PSA after radiation and androgen deprivation therapy can help predict prostate cancer outcomes. Meanwhile, a new genomic test is showing potential for identifying which patients face higher risk of long-term urinary side effects. keep reading

Why do some radiation side effects show up right away while others don’t appear for years? Understanding the difference between early and late effects—and how new approaches are lowering risks—can help patients prepare for treatment with greater confidence. keep reading

Not all biopsies are created equal. When it comes to planning radiation treatment, real-time MRI guidance makes all the difference. Learn how this advanced approach helps doctors target cancer more precisely and reduce the risk of prostate cancer returning. keep reading

Radiation doesn’t always mean the end of prostate cancer. Could focal therapy offer hope for recurrence? A new study on MRI-guided TULSA sheds light on benefits—and risks—that patients should know. keep reading

“I’m sorry to say your prostate cancer has recurred.” No one wants to hear that message after an initial whole-gland treatment like surgery or radiation. While 5-year survival rates for localized prostate cancer approach 100%, over the longer term as many as 20-40% of patients will experience recurrence. Recurrence after radiation treatment offers a unique opportunity... keep reading

The term “biochemical failure” means the presence of a rising PSA after any prostate cancer treatment. In fact, a rising PSA is the gold standard for suspecting prostate cancer recurrence (the cancer has come back). However, a precise, universal standard for defining biochemical failure is difficult because... keep reading